0001387131-15-001496.txt : 20150710 0001387131-15-001496.hdr.sgml : 20150710 20150506161736 ACCESSION NUMBER: 0001387131-15-001496 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465622433 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 682-8452 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 CORRESP 1 filename1.htm

May 5, 2015

James Kardon
Partner

212.478.7250

jkardon@hahnhessen.com

Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549

Attention:		Jim B. Rosenberg
		Senior Assistant Chief Accountant


Re:		Ohr Pharmaceutical, Inc. Form 10-K for the Fiscal Year Ended September 30, 2014 Filed December 22, 2014 File No. 001-35963

Greetings:

We are in receipt of the Staff’s letter of comment, dated April 22, 2015. On behalf of Ohr Pharmaceutical, Inc. (“Ohr” or the “Company”), we request an extension of Ohr’s time to respond to May 18, 2015.

		Very truly yours,


		/s/ James Kardon

		James Kardon


cc:	Irach Taraporewala
	Sam Backenroth